Changes in serum levels of MDA and MMP-9 after UPF in patients with OSAS

European Archives of Oto-Rhino-Laryngology

Volumn 271, Issue 5, 2014, Pages 1329-1334

  Vuralkan, Erkan ^a   Mutlu, Murad ^b   Firat, Ibrahim Hikmet ^b   Akaydin, Sevgi ^c   Sagit, Mustafa ^d   Akin, Istemihan ^b   Miser, Ece ^c   Ardic, Sadik ^b  

^a Trabzon Kanuni Training and Research Hospital   (Turkey)

^b DISKAPI YILDIRIM BEYAZIT TRAINING AND RESEARCH HOSPITAL   (Turkey)

^c GAZI UNIVERSITY   (Turkey)

^d Faculty of Pharmacy Gazi University ^*  (Turkey)

Author keywords

Malondialdehyde; Matrix metalloproteinase 9; OSAS; Uvulopalatal flap surgery

Indexed keywords

GELATINASE B; MALONALDEHYDE; MMP9 PROTEIN, HUMAN;

ADULT; APNEA HYPOPNEA INDEX; BLOOD SAMPLING; CLINICAL ARTICLE; CONFERENCE PAPER; FEMALE; HUMAN; LIPID PEROXIDATION; MALE; MIDDLE AGED; POLYSOMNOGRAPHY; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; SLEEP DISORDERED BREATHING; TISSUE FLAP; TREATMENT OUTCOME; UVULOPALATAL FLAP; BLOOD; FOLLOW UP; PALATE; POSTOPERATIVE COMPLICATIONS; SLEEP APNEA, OBSTRUCTIVE; SURGERY; SURGICAL FLAPS;

ADULT; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MALONDIALDEHYDE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; PALATE; POLYSOMNOGRAPHY; POSTOPERATIVE COMPLICATIONS; SLEEP APNEA, OBSTRUCTIVE; SURGICAL FLAPS; TREATMENT OUTCOME; UVULA;

EID: 84898903285     PISSN: 09374477     EISSN: 14344726     Source Type: Journal    
DOI: 10.1007/s00405-013-2821-5     Document Type: Conference Paper

References (24)

1. Douglas NJ, Polo O (1994) Pathogenesis of sleep apnoea/hypopnoea syndrome. Lancet 344:653-655. doi: 10.1016/S0140-6736(94)92088-5
2. Schulz R, Mahmoudi S, Hattar K et al (2000) Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea: impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med 162:566-570. doi: 10.1164/ajrccm.162.2.9908091
3. Shahar E, Whitney CW, Redline S et al (2001) Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the sleep heart health study. Am J Respir Crit Care Med 163:19-25. doi: 10.1164/ajrccm.163.1.2001008
4. Peker Y, Hedner J, Norum J, Kraiczi H, Carlson J (2002) Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: a 7-year follow up. Am J Respir Crit Care Med 166:159-165. doi: 10.1164/rccm.2105124
5. Visse R, Nagase H (2003) Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 92:827-839. doi: 10.1161/01.RES.0000070112.80711.3D
6. Carrell TW, Burnand KG, Wells GM, Clements JM, Smith A (2002) Stromelysin-1 (matrix metalloproteinase-3) and tissue inhibitor of metalloproteinase-3 are overexpressed in the wall of abdominal aortic aneurysms. Circulation 105:477-482
7. Kai H, Ikeda H, Yasukawa H et al (1998) Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes. J Am Coll Cardiol 32:368-372
8. Blankenberg S, Rupprecht HJ, Poirier O et al (2003) Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease. Circulation 107:1579-1585
9. Kondo S, Kubota S, Shimo T et al (2002) Connective tissue growth factor increased by hypoxia may initiate angiogenesis in collaboration with matrix metalloproteinases. Carcinogenesis 23:769-776. doi: 10.1093/carcin/23.5.769
10. Requena JR, Fu MX, Ahmed MU et al (1997) Quantification of malondialdehyde and 4-hydroxynonenal adducts to lysine residues in native and oxidized human low-density lipoprotein. Biochem J 322(Pt 1):317-325
11. Slatter DA, Paul RG, Murray M, Bailey AJ (1999) Reactions of lipid-derived malondialdehyde with collagen. J Biol Chem 274:19661-19669. doi: 10.1074/jbc.274.28.19661
12. Mehmetcik G, Ozdemirler G, Kanbagli O, Toker G, Uysal M (1997) Age-related changes in plasma lipid peroxidation and antioxidant system in humans and rats. Arch Gerontol Geriatr 25:305-310 PII: S0167-4943(97)00023-X
13. Pilz J, Meineke I, Gleiter CH (2000) Measurement of free and bound malondialdehyde in plasma by high-performance liquid chromatography as the 2,4-dinitrophenylhydrazine derivative. J Chromatogr 742:315-325. doi: 10.1016/S0378-4347(00)00174-2
14. Lavie L (2003) Obstructive sleep apnea syndrome -an oxidative stress disorder. Sleep Med Rev 7:35-51. doi: 10.1053/smrv2002.0261
15. Rajagopalan S, Ramasamy S, Meng XP, Harrison DG, Galis ZS (1996) Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrixmetalloproteinases in vitro. Implications for atherosclerotic plaque stability. J Clin Invest 98:2572-2579. doi: 10.1172/JCI119076
16. Godin D, Ivan E, Johnson C, Magid R, Galis ZS (2000) Remodeling of carotid artery is associated with increased expression of matrix metalloproteinases in mouse blood flow cessationmodel. Circulation 102:2861-2866. doi: 10.1161/01.CIR.102.23.2861
17. Sundstrom J, Evans JC, Benjamin EJ et al (2004) Relations of plasma matrix metalloproteinase-9 to clinical cardiovascular risk factors and echocardiographic left ventricular measures: the Framingham Heart Study. Circulation 109:2850-2856. doi: 10.1161/01.CIR.0000129318.79570.84
18. Szmitko PE, Wang CH, Weisel RD, Jeffries GA, Anderson TJ, Verma S (2003) Biomarkers of vascular disease linking inflammation to endothelial activation: part II. Circulation 108:2041-2048. doi: 10.1161/01.CIR.0000089093.75585.98
19. Kossakowska AE, Edwards DR, Prusinkiewicz C et al (1999) Interleukin-6 regulation of matrix metalloproteinase (MMP-2 and MMP-9) and tissue inhibitor of metalloproteinase (TIMP-1) expression in malignant non-Hodgkin's lymphomas. Blood 94:2080-2089
20. Kenagy RD, Hart CE, Stetler-Stevenson WG, Clowes AW (1997) Primate smooth muscle cell migration from aortic explants is mediated by endogenous platelet-derived growth factor and basic fibroblast growth factor acting through matrix metalloproteinases 2 and 9. Circulation 96:3555-3560. doi: 10.1161/01.CIR.96.10.3555
21. Tazaki T, Minoguchi K, Yokoe T et al (2004) Increased levels and activity of matrix metalloproteinase-9 in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 170:1354-1359
22. Jordan W, Cohrs S, Degner D et al (2006) Evaluation of oxidative stress measurements in obstructive sleep apnea syndrome. J Neural Transm 113:239-254. doi: 10.1007/s00702-005-0316-2
23. Cofta S, Wysocka E, Piorunek T, Rzymkowska M, Batura-Gabryel H, Torlinski L (2008) Oxidative stres markers in the blood of persons with different stages of obstructive sleep apnea syndrome. J Physiol Pharmacol 59(Suppl 6):183-190
24. Tafil-Klawe M, Laudencka A, Klawe JJ, Miśkowiec I (2005) Does night work favor sleep-related accidents in police officers? J Physiol Pharmacol 56(Suppl 4):223-226